|
|
|
Volumn 7, Issue 6, 2007, Pages 446-447
|
|
Phase III trial comparing fulvestrant with exemestane in patients with advanced breast cancer in whom previous nonsteroidal aromatase inhibitor therapy has failed
a a a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANASTROZOLE;
AROMATASE INHIBITOR;
ESTROGEN RECEPTOR;
EXEMESTANE;
FULVESTRANT;
LETROZOLE;
PLACEBO;
PROGESTERONE RECEPTOR;
TAMOXIFEN;
ADJUVANT THERAPY;
ADULT;
ADVANCED CANCER;
ARTHROPATHY;
BREAST CANCER;
CANCER GROWTH;
CANCER RECURRENCE;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
DRUG DOSE REDUCTION;
DRUG EFFICACY;
DRUG FATALITY;
DRUG SAFETY;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
FEMALE;
HORMONAL THERAPY;
HOT FLUSH;
HUMAN;
INJECTION SITE REACTION;
MAJOR CLINICAL STUDY;
NAUSEA;
PHASE 3 CLINICAL TRIAL;
POSTMENOPAUSE;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT FAILURE;
TREATMENT RESPONSE;
VISCERAL METASTASIS;
VOMITING;
|
|
EID: 33947289054
PISSN: 15268209
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (3)
|
|
References (0)
|